Front Row Advisors LLC Gilead Sciences, Inc. Transaction History

Front Row Advisors LLC

$282 Million
Q2 2024

A detailed history of Front Row Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Front Row Advisors LLC holds 1,581 shares of GILD stock, worth $133,072. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,581

Previous 1,581 -0.0%

Holding current value

$133,072

Previous $115,000 6.09%

% of portfolio

0.04%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $56,906 - $69,395	795 Added 101.15%	1,581 $115,000
Q1 2023 May 22, 2023	BUY	$77.31 - $88.08 $55,740 - $63,505	721 Added 1109.23%	786 $65,000
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $44,839 - $51,086	-580 Reduced 89.92%	65 $79,000
Q4 2022 Feb 15, 2023	SELL	$62.32 - $89.47 $8,787 - $12,615	-141 Reduced 17.94%	645 $55,000
Q3 2022 Nov 15, 2022	BUY	$59.54 - $68.01 $59 - $68	1 Added 0.13%	786 $49,000
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $115 - $130	2 Added 0.26%	785 $49,000
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $115 - $145	2 Added 0.26%	783 $46,000
Q4 2021 Mar 09, 2022	SELL	$64.88 - $73.64 $16,155 - $18,336	-249 Reduced 24.17%	781 $57,000
Q3 2021 Nov 03, 2021	BUY	$67.69 - $73.03 $67 - $73	1 Added 0.1%	1,030 $72,000
Q2 2021 Aug 23, 2021	BUY	$63.47 - $69.35 $126 - $138	2 Added 0.19%	1,029 $74,000
Q1 2021 Apr 28, 2021	BUY	$60.0 - $68.46 $60 - $68	1 Added 0.1%	1,027 $66,000
Q4 2020 Feb 25, 2021	BUY	$56.65 - $64.55 $113 - $129	2 Added 0.2%	1,026 $60,000
Q3 2020 Nov 30, 2020	SELL	$62.1 - $78.08 $15,090 - $18,973	-243 Reduced 19.18%	1,024 $61,000
Q2 2020 Aug 17, 2020	BUY	$72.34 - $84.0 $72 - $84	1 Added 0.08%	1,267 $97,000
Q1 2020 May 08, 2020	BUY	$62.63 - $80.22 $37,264 - $47,730	595 Added 88.67%	1,266 $106,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $61 - $67	1 Added 0.15%	671 $44,000
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $1,312 - $1,449	-21 Reduced 3.04%	670 $42,000
Q2 2019 Aug 27, 2019	BUY	$61.87 - $69.38 $31,677 - $35,522	512 Added 286.03%	691 $47,000
Q1 2019 May 17, 2019	BUY	$62.53 - $70.05 $6,628 - $7,425	106 Added 145.21%	179 $12,000
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $6,272 - $6,944	-88 Reduced 54.66%	73 $5,000
Q2 2018 Jul 31, 2018	BUY	$64.88 - $75.68 $1,492 - $1,740	23 Added 16.67%	161 $13,000
Q1 2018 May 21, 2018	BUY	$72.84 - $88.8 $3,642 - $4,440	50 Added 56.82%	138 $10,000
Q4 2017 Feb 01, 2018	BUY	$71.15 - $83.52 $6,261 - $7,349	88	88 $6,000

Others Institutions Holding GILD

# of Institutions

1,880

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.

Account

Front Row Advisors LLC Gilead Sciences, Inc. Transaction History